United’s Martine Rothblatt endorses a biotech unicorn’s CEO and antes up for US rights to an IPF drug
United Therapeutics Martine Rothblatt has joined the pack of admirers backing one of the industry’s most intriguing biotech unicorns.
Just a few months after gaining …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.